Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Legend Biotech
Pharma
ASH: J&J pressures CAR-T with Tecvayli combo in 2L myeloma
The Tecvayli-Darzalex combo’s overall survival curve flattened, suggesting the potential of a cure.
Angus Liu
Dec 9, 2025 7:30am
J&J, Legend pull ASH paper comparing Carvykti to rival CAR-T
Nov 12, 2025 11:36am
Cabaletta picks up the pace with new CCO from Legend, Celgene
Oct 14, 2025 12:42pm
FDA warns of intestinal disorder risk with use of J&J's Carvykti
Oct 13, 2025 11:16am
GSK-Hengrui, Takeda, Celltrion—Fierce Pharma Asia
Aug 1, 2025 9:00am
J&J, Legend debut first TV ad for multiple myeloma med Carvykti
Jul 30, 2025 2:56pm
